Philadelphia, Pennsylvania, New Jersey, Nationwide
AlloDerm is a biological mesh patch created from donated human tissue and used primarily in the repair of hernias, although AlloDerm has also been used in breast reconstruction, abdominal wall repair, burn treatment and other procedures necessitating skin grafts.
Introduced in 1994, AlloDerm hernia patches have in recent years been shown to have a substantial failure rate and increase the risk for some medical complications. The Philadelphia product liability attorneys at Golomb & Honik are currently investigating claims from AlloDerm recipients in Pennsylvania, New Jersey and throughout the United States who may have suffered complications as a result of faulty mesh patches.
Reported complications with AlloDerm patches include:
- Adhesion problems
- Mesh erosion
- Mesh perforation
- Mesh tearing
These failures can result in:
- Abscess development
- Hernia recurrence
- Infection
- Inflammation
- Pain
- Organ damage
Although AlloDerm makers LifeCell voluntarily recalled some biological surgical mesh products in 2005, that recall was related less to the potential dangers of their products than allegations that the company harvested tissue from cadavers without proper authority.
Those who experience complications from AlloDerm patches often require revision surgery.
If you suffered harm due to an AlloDerm hernia mesh patch, please contact the Philadelphia dangerous medical device attorneys at Golomb & Honik for your no-cost case evaluation. We represent clients from Pennsylvania, New Jersey and nationwide.
